<DOC>
	<DOCNO>NCT00002563</DOCNO>
	<brief_summary>RATIONALE : Quality-of-life assessment patient undergoing cancer treatment may help determine intermediate- long-term effect treatment patient cancer . PURPOSE : This clinical trial study impact therapy health status quality life patient stage I stage II Hodgkin 's disease receiving radiation therapy without chemotherapy .</brief_summary>
	<brief_title>SWOG-9208 Quality Life Health Status Patients With Stage I Stage II Hodgkin 's Disease</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate prospectively health status quality life patient Stage I/IIA Hodgkin 's disease randomize protocol SWOG-9133 ( CLB-9391 ) treatment subtotal nodal irradiation vs. without 3 course doxorubicin/vinblastine . II . Describe short-term effect treatment patient compare impact quality life ( i.e. , patient symptom status , health status , fatigue ) . III . Evaluate intermediate long-term effect treatment patient compare impact quality-of-life outcome 5 year . OUTLINE : Quality-of-Life Assessment . Cancer Rehabilitation Evaluation System Short Form , CARES-SF ; Symptom Personal Information Questionnaire ( include Symptom Distress Scale , MOS SF-36 Fatigue Scale , MOS SF-36 Health Perception Rating , Demographics ) ; Cover Sheet . PROJECTED ACCRUAL : Approximately 500 patient accrue 7 year .</detailed_description>
	<mesh_term>Hodgkin Disease</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients must eligible registered SWOG9133 PATIENT CHARACTERISTICS : Patients must able complete questionnaire English . If able complete questionnaire English , patient may register SWOG9133 without participate SWOG9208 . The Symptom Personal Information Questionnaire # 1 , Cancer Rehabilitation Evaluation System Short Form ( CARESSF ) Cover Sheet must complete prior registration randomization SWOG9133 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>stage I adult Hodgkin lymphoma</keyword>
	<keyword>stage II adult Hodgkin lymphoma</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
</DOC>